Scott Thomas Smith
Vermögen: 978 688 $ am 31.05.2026
Vermögen: 978 688 $ am 31.05.2026
Gegenwärtig bekleidet Scott Thomas Smith die Position des Chief Financial Officer & Senior Vice President von Ascendis Pharma A. Zuvor bekleidete er die Position des Director-Healthcare Investment Banking Group bei Wedbush Securities, Inc. und Director-Global Healthcare Investment Banking bei Merrill Lynch, Pierce, Fenner & Smith, Inc. Herr Smith erhielt einen Undergraduate-Abschluss vom Claremont McKenna College und einen MBA von der Stanford Graduate School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ASCENDIS PHARMA A/S 0.01% | 02.06.2026 | 4’367 ( 0.01% ) | 978 688 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ASCENDIS PHARMA A/S | Finanzdirektor/CFO | 08.08.2016 |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Finanzdirektor/CFO | 01.08.2016 |
| Unternehmen | Position | Ende |
|---|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Corporate Officer/Principal | 01.01.2016 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Claremont McKenna College
Claremont McKenna College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen